Tim Newman

Brighton

Science Communications Writer at ZOE

Keen on science, nature, heavy metal, and dinosaurs. Twin dad. Senior News Editor at https://t.co/SmDgepBTcO (views are my own).

Articles

Fart Walking Is TikTok’s New Trend for Digestive Health: Does It Work?

1 week ago | healthline.com | Tim Newman

Share on PinterestA new viral TikTok trend known as “fart walking” involves going for a stroll after eating to help release gas. Proponents say a fart walk helps promote digestive health, while regular fart walking could reduce the risk of type 2 diabetes by preventing blood sugar spikes. While the benefits of this health hack lack scientific evidence, research supports the benefits of movement, particularly after a meal.
56 lifestyle factors linked to risk

2 weeks ago | medicalnewstoday.com | Tim Newman

Share on PinterestSudden cardiac arrest is a serious and often fatal condition. For the first time, a new study investigates the factors that increase the risk of sudden cardiac arrest. The researchers identify more than 50 factors associated with increased or decreased risk. Sudden cardiac arrest occurs when the heart suddenly stops entirely or fails to pump adequately. Because of its sudden nature, it is often fatal.
Alzheimer's risk significantly lower for semaglutide, SGLT2 drug users

1 month ago | resources.healthgrades.com | Tim Newman

A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes. The scientists found that two medications significantly reduce the risk of developing dementia in life.
Alzheimer's risk significantly lower for semaglutide, SGLT2 drug users

1 month ago | medicalnewstoday.com | Tim Newman

Share on PinterestA new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes. The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias.
Not enough time in 2 deep sleep stages may increase risk

1 month ago | medicalnewstoday.com | Tim Newman

Share on PinterestEarlier studies have identified a relationship between sleep and Alzheimer’s disease. A new study looks in detail at sleep phases, brain changes, and Alzheimer’s disease. According to the results, reductions in certain types of sleep are linked to reduced volume in brain areas involved in Alzheimer’s. Understanding the risk factors associated with Alzheimer’s disease is a hot topic.
Anti-amyloid drug may reduce disease risk by 50%

1 month ago | medicalnewstoday.com | Tim Newman

Share on PinterestA recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more than 50%. A new study provides a well-needed glimmer of hope for treating Alzheimer’s disease.
5 ways to reduce exposure

2 months ago | medicalnewstoday.com | Tim Newman

Share on PinterestThe link between microplastics and health is a rapidly evolving area of science. A recent commentary reviews this relationship, particularly focusing on brain health. The authors also outline ways to reduce exposure to microplastics. A new commentary article, which appears in the journal Brain Medicine, discusses microplastics and their links to health.
New test may help detect neurofibrillary tangles early

2 months ago | medicalnewstoday.com | Tim Newman

Share on PinterestThe presence of neurofibrillary tangles in the brain is one of the key hallmarks of Alzheimer’s disease. These irregular clumps of protein are closely associated with disease progression. Scientists have now designed a way to detect the very early stages of their development. They hope this discovery will pave the way for earlier diagnosis and, therefore, better response to treatment.
New test may detect Alzheimer's years before tau clumps show up in scans

Feb 14, 2025 | aol.com | Tim Newman

The presence of neurofibrillary tangles in the brain is one of the key hallmarks of Alzheimer’s disease. These irregular clumps of protein are closely associated with disease progression. Scientists have now designed a way to detect the very early stages of their development. They hope this discovery will pave the way for earlier diagnosis and, therefore, better response to treatment. Scientists know that a build-up of specific proteins in the brain is associated with Alzheimer’s disease.
New test may detect Alzheimer's years before tau clumps show up in scans

Feb 14, 2025 | resources.healthgrades.com | Tim Newman

The presence of neurofibrillary tangles in the brain is one of the key hallmarks of Alzheimer’s disease. These irregular clumps of protein are closely associated with disease progression. Scientists have now designed a way to detect the very early stages of their development. They hope this discovery will pave the way for earlier diagnosis and, therefore, better response to treatment. Scientists know that a build-up of specific proteins in the brain is associated with Alzheimer’s disease.